1. Home
  2. NCRA vs PHGE Comparison

NCRA vs PHGE Comparison

Compare NCRA & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCRA
  • PHGE
  • Stock Information
  • Founded
  • NCRA 2002
  • PHGE 2015
  • Country
  • NCRA Taiwan
  • PHGE Israel
  • Employees
  • NCRA N/A
  • PHGE N/A
  • Industry
  • NCRA Farming/Seeds/Milling
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCRA Consumer Staples
  • PHGE Health Care
  • Exchange
  • NCRA Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • NCRA 12.6M
  • PHGE 11.1M
  • IPO Year
  • NCRA N/A
  • PHGE N/A
  • Fundamental
  • Price
  • NCRA $0.93
  • PHGE $0.61
  • Analyst Decision
  • NCRA
  • PHGE Strong Buy
  • Analyst Count
  • NCRA 0
  • PHGE 2
  • Target Price
  • NCRA N/A
  • PHGE $22.50
  • AVG Volume (30 Days)
  • NCRA 8.0K
  • PHGE 73.2K
  • Earning Date
  • NCRA 08-14-2024
  • PHGE 11-14-2024
  • Dividend Yield
  • NCRA N/A
  • PHGE N/A
  • EPS Growth
  • NCRA N/A
  • PHGE N/A
  • EPS
  • NCRA N/A
  • PHGE N/A
  • Revenue
  • NCRA $20,483,694.00
  • PHGE N/A
  • Revenue This Year
  • NCRA N/A
  • PHGE N/A
  • Revenue Next Year
  • NCRA N/A
  • PHGE N/A
  • P/E Ratio
  • NCRA N/A
  • PHGE N/A
  • Revenue Growth
  • NCRA N/A
  • PHGE N/A
  • 52 Week Low
  • NCRA $0.70
  • PHGE $0.48
  • 52 Week High
  • NCRA $1.54
  • PHGE $8.55
  • Technical
  • Relative Strength Index (RSI)
  • NCRA 45.05
  • PHGE 42.68
  • Support Level
  • NCRA $0.70
  • PHGE $0.61
  • Resistance Level
  • NCRA $1.14
  • PHGE $0.69
  • Average True Range (ATR)
  • NCRA 0.10
  • PHGE 0.08
  • MACD
  • NCRA -0.01
  • PHGE 0.01
  • Stochastic Oscillator
  • NCRA 51.40
  • PHGE 10.05

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Share on Social Networks: